Reducing pre-clinical blood volumes for toxicokinetics: toxicologists, pathologists and bioanalysts unite-Reference-Cited by-同舟云学术

Reducing pre-clinical blood volumes for toxicokinetics: toxicologists, pathologists and bioanalysts unite

Published:2014-11 Issue:22 Volume:6 Page:2965-2968
ISSN:1757-6180
Container-title:Bioanalysis
language:en
Short-container-title:Bioanalysis

Author:

Chapman Kathryn¹,Burnett Josephine²,Corvaro Marco³,Mitchell David⁴,Robinson Sally⁵,Sangster Timothy⁶,Sparrow Susan⁷,Spooner Neil⁷,Wilson Amanda⁵

Affiliation:

1. National Centre for the Replacement, Refinement & Reduction of Animals in Research (NC3Rs), London, UK

2. Covance Laboratories, Harrogate, UK

3. Dow AgroSciences, UK

4. Huntingdon Life Sciences, Huntingdon, UK

5. Astra Zeneca, Macclesfield, UK

6. Charles River Laboratories, Edinburgh, UK

7. Glaxo Smith Kline, Ware, UK

Publisher

Future Science Ltd

Subject

Medical Laboratory Technology,Clinical Biochemistry,General Pharmacology, Toxicology and Pharmaceutics,General Medicine,Analytical Chemistry

Link

http://www.future-science.com/doi/pdf/10.4155/bio.14.204

Reference21 articles.

1. Test No. 426: Developmental Neurotoxicity Study

2. Test No. 417: Toxicokinetics

3. OECD. Guidance document 116 on the conduct and design of chronic toxicity and carcinogenicity studies supporting test guidelines 451, 452 and 453. 2nd Edition. OECD Publishing, Paris, France, 47 (2012).

4. OECD. Series on testing and assessment no. 151. Guidance document supporting OECD test guideline 443 on the extended one generation reproductiove toxicity study. (ENV/JM/MONO10. OECD, Paris, France (2013).

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The 3Rs in Experimental Liver Disease;Animals;2023-07-19

2. Impact of repeated micro and macro blood sampling on clinical chemistry and haematology in rats for toxicokinetic studies;Regulatory Toxicology and Pharmacology;2023-06

3. Species Selection for Pharmaceutical Toxicity Studies;Drug Discovery and Evaluation: Safety and Pharmacokinetic Assays;2023

4. Animal use and opportunities for reduction in carcinogenicity studies supporting approved new drug applications in the U.S., 2015–2019;Regulatory Toxicology and Pharmacology;2023-01

5. Toxicokinetics in preclinical drug development of small‐molecule new chemical entities;Biomedical Chromatography;2022-12-13